A change in federal distribution policy has prompted concerns among providers that vulnerable older adults in long-term care facilities may not have timely access to monoclonal antibody therapy to treat COVID-19.
A change in federal distribution policy has prompted concerns among providers that vulnerable older adults in long-term care facilities may not have timely access to monoclonal antibody therapy to treat COVID-19.